B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience | Annals of the Rheumatic Diseases
Immunosuppressive therapy with rituximab in common variable immunodeficiency | Clinical and Molecular Allergy | Full Text
Frontiers | Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications
B-Cell Targeted Therapies: Clinical Trials Update
Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management | European Respiratory Society
GPA & MPA | RITUXAN® (rituximab) Proposed Mechanism of Action (MoA)
Rituximab Use in Pediatric Dermatology - JDDonline - Journal of Drugs in Dermatology
Rheumatoid arthritis, other inflammatory arthritides and osteoarthritis - Medical Pharmacology and Therapeutics, 4e
Biological Therapy for Rheumatoid Arthritis - ppt download
2014 Update of the Consensus Statement of the Spanish Society of Rheumatology on the Use of Biological Therapies in Rheumatoid Arthritis | Reumatología Clínica
Rheumatoid arthritis - The Lancet
Rituximab in dermatology | Actas Dermo-Sifiliográficas
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
Novel therapeutic targets in rheumatoid arthritis: Trends in Pharmacological Sciences
New Drugs for Rheumatoid Arthritis | NEJM
Frontiers | Rituximab Therapy for Primary Sjögren's Syndrome
Role of biological agents in treatment of rheumatoid arthritis - ScienceDirect
B-Cell Targeted Therapies: Clinical Trials Update
Internet Scientific Publications
Truxima (rituximab) for the Treatment of Cancer - Clinical Trials Arena
Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective | Critical Care | Full Text
Cells | Free Full-Text | Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies
